Mark J. Murray

CIK 1628383 · President and CEO · last filed 2019-03-05

Mark J. Murray is a President and CEO who has filed 10 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for ABUS, was dated Mar 5, 2019. Current disclosed insider exposure totals $1.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.56M

Companies

2

Total Filings

10

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ABUS President and CEO 341,396 $4.56 $1.56M $0 9 2019-03-05
Arbutus Biopharma Corp (TKMR) Delisted President & CEO $0 1 2015-04-02

Recent Filings

10 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-03-05 ABUS Grant (A) $0 EDGAR
2018-11-30 ABUS Exer (M) +25,000 $33.8K EDGAR
2018-04-17 ABUS Mixed +27,007 $9.6K EDGAR
2017-04-05 ABUS Grant (A) $0 EDGAR
2016-06-20 ABUS Exer (X) +5,000 $12.8K EDGAR
2016-03-17 ABUS Grant (A) $0 EDGAR
2016-01-06 ABUS Grant (A) $0 EDGAR
2015-12-22 ABUS Grant (A) $0 EDGAR
2015-09-15 ABUS Exer (M) +219,428 $97.5K EDGAR
2015-04-02 Arbutus Biopharma Corp (TKMR) Delisted Grant (A) $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.